The independent source for health policy research, polling, and news.
81-100 of 156 results
Sen. Ron Wyden (D-Ore.), chair of the Senate Finance Committee, vowed to meet monthly with Social Security officials until the problems surrounding overpayment demands are fixed.
A chronic health diagnosis and medical debt reordered Sharon Woodward's life.
More than 2 million people a year have been sent notices that Social Security overpaid them and demanding they repay the money. That’s twice as many as the head of Social Security disclosed at a congressional hearing in October.
Long-term care options in the U.S. are costly, complex, and often inadequate. KFF Health News' Jordan Rau and Reed Abelson of The New York Times host a Zoom panel to explore the challenges of providing — and affording — care.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma — which marketed OxyContin — could claim immunity from future lawsuits without claiming bankruptcy.
At least 17 states have issued PFAS-related fish consumption advisories, KFF Health News found. But with no federal guidance, what is considered safe to eat varies significantly among states, most of which provide no regulation.
KFF Health News editor-at-large for public health Céline Gounder discusses how families of transgender youth are uprooting their lives due to anti-trans policies and their ripple effects.
A conversation about how the lessons from the victory over smallpox could be applied to public health challenges today.
This installment of InvestigateTV and KFF Health News' “Costly Care” series delves into the lack of cost protections for patients who find themselves on the hook for an emergency ground ambulance ride.
Stark, plaintive testimony from women denied abortion care represents the start of “the 50-year fight to get rid of Dobbs,” one historian says.
KFF Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling surrounding drugmaker Purdue Pharma's role in the opioid crisis and her reporting into the ongoing distribution of opioid settlement funds.
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
At least two Idaho hospitals are ending labor and delivery services, with one citing the state’s “legal and political climate” and noting that “recruiting replacements will be extraordinarily difficult” as doctors leave.
Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn’t clear whether Sanders will succeed in even that, but he has put affordability front and center.
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
A Donald Trump-appointed federal judge agreed that even the possibility that the father’s daughters might access contraception without his permission violated the tenants of his Christian faith.
This installment of InvestigateTV and KHN’s “Costly Care” series looks at the case of a New Orleans woman whose thumb injury saddled her with a big ER bill for a tetanus shot and some minor care.
Under pressure from Republican attorneys general, the nation's second-largest pharmacy chain says it will not dispense the abortion pill mifepristone.
“What happens in Texas doesn't stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
© 2026 KFF